477 related articles for article (PubMed ID: 29500465)
1. The role of osteopontin in the progression of solid organ tumour.
Zhao H; Chen Q; Alam A; Cui J; Suen KC; Soo AP; Eguchi S; Gu J; Ma D
Cell Death Dis; 2018 Mar; 9(3):356. PubMed ID: 29500465
[TBL] [Abstract][Full Text] [Related]
2. Osteopontin: an emerging therapeutic target for anticancer therapy.
Jain S; Chakraborty G; Bulbule A; Kaur R; Kundu GC
Expert Opin Ther Targets; 2007 Jan; 11(1):81-90. PubMed ID: 17150036
[TBL] [Abstract][Full Text] [Related]
3. Osteopontin as a therapeutic target for cancer.
Bandopadhyay M; Bulbule A; Butti R; Chakraborty G; Ghorpade P; Ghosh P; Gorain M; Kale S; Kumar D; Kumar S; Totakura KV; Roy G; Sharma P; Shetti D; Soundararajan G; Thorat D; Tomar D; Nalukurthi R; Raja R; Mishra R; Yadav AS; Kundu GC
Expert Opin Ther Targets; 2014 Aug; 18(8):883-95. PubMed ID: 24899149
[TBL] [Abstract][Full Text] [Related]
4. The role of osteopontin expression in melanoma progression.
Kiss T; Ecsedi S; Vizkeleti L; Koroknai V; Emri G; Kovács N; Adany R; Balazs M
Tumour Biol; 2015 Sep; 36(10):7841-7. PubMed ID: 25944164
[TBL] [Abstract][Full Text] [Related]
5. Osteopontin as a target for cancer therapy.
Johnston NI; Gunasekharan VK; Ravindranath A; O'Connell C; Johnston PG; El-Tanani MK
Front Biosci; 2008 May; 13():4361-72. PubMed ID: 18508515
[TBL] [Abstract][Full Text] [Related]
6. Correlation of osteopontin protein expression and pathological stage across a wide variety of tumor histologies.
Coppola D; Szabo M; Boulware D; Muraca P; Alsarraj M; Chambers AF; Yeatman TJ
Clin Cancer Res; 2004 Jan; 10(1 Pt 1):184-90. PubMed ID: 14734468
[TBL] [Abstract][Full Text] [Related]
7. Osteopontin: its potential role in cancer of children and young adults.
Karpinsky G; Fatyga A; Krawczyk MA; Chamera M; Sande N; Szmyd D; Izycka-Swieszewska E; Bien E
Biomark Med; 2017 Apr; 11(4):389-402. PubMed ID: 28326824
[TBL] [Abstract][Full Text] [Related]
8. Role of the metastasis-promoting protein osteopontin in the tumour microenvironment.
Anborgh PH; Mutrie JC; Tuck AB; Chambers AF
J Cell Mol Med; 2010 Aug; 14(8):2037-44. PubMed ID: 20597997
[TBL] [Abstract][Full Text] [Related]
9. OPN-a Splicing Variant Expression in Non-small Cell Lung Cancer and its Effects on the Bone Metastatic Abilities of Lung Cancer Cells
Hao C; Cui Y; Hu MU; Zhi X; Zhang L; Li W; Wu W; Cheng S; Jiang WG
Anticancer Res; 2017 May; 37(5):2245-2254. PubMed ID: 28476789
[TBL] [Abstract][Full Text] [Related]
10. Osteopontin Promotes Cell Migration and Invasion, and Inhibits Apoptosis and Autophagy in Colorectal Cancer by activating the p38 MAPK Signaling Pathway.
Huang RH; Quan YJ; Chen JH; Wang TF; Xu M; Ye M; Yuan H; Zhang CJ; Liu XJ; Min ZJ
Cell Physiol Biochem; 2017; 41(5):1851-1864. PubMed ID: 28376477
[TBL] [Abstract][Full Text] [Related]
11. Bone sialoprotein and osteopontin in bone metastasis of osteotropic cancers.
Kruger TE; Miller AH; Godwin AK; Wang J
Crit Rev Oncol Hematol; 2014 Feb; 89(2):330-41. PubMed ID: 24071501
[TBL] [Abstract][Full Text] [Related]
12. Osteopontin: regulation in tumor metastasis.
Wai PY; Kuo PC
Cancer Metastasis Rev; 2008 Mar; 27(1):103-18. PubMed ID: 18049863
[TBL] [Abstract][Full Text] [Related]
13. SIBLINGs and SPARC families: their emerging roles in pancreatic cancer.
Kaleağasıoğlu F; Berger MR
World J Gastroenterol; 2014 Oct; 20(40):14747-59. PubMed ID: 25356037
[TBL] [Abstract][Full Text] [Related]
14. Abrogation of the interaction between osteopontin and alphavbeta3 integrin reduces tumor growth of human lung cancer cells in mice.
Cui R; Takahashi F; Ohashi R; Gu T; Yoshioka M; Nishio K; Ohe Y; Tominaga S; Takagi Y; Sasaki S; Fukuchi Y; Takahashi K
Lung Cancer; 2007 Sep; 57(3):302-10. PubMed ID: 17482311
[TBL] [Abstract][Full Text] [Related]
15. Thrombin Cleavage of Osteopontin and the Host Anti-Tumor Immune Response.
Leung LL; Myles T; Morser J
Cancers (Basel); 2023 Jul; 15(13):. PubMed ID: 37444590
[TBL] [Abstract][Full Text] [Related]
16. The multifaceted roles of osteopontin in cell signaling, tumor progression and angiogenesis.
Chakraborty G; Jain S; Behera R; Ahmed M; Sharma P; Kumar V; Kundu GC
Curr Mol Med; 2006 Dec; 6(8):819-30. PubMed ID: 17168734
[TBL] [Abstract][Full Text] [Related]
17. [SIBLING proteins: molecular tools for tumor progression and angiogenesis].
Lamour V; Nokin MJ; Henry A; Castronovo V; Bellahcène A
Med Sci (Paris); 2013 Nov; 29(11):1018-25. PubMed ID: 24280506
[TBL] [Abstract][Full Text] [Related]
18. Osteopontin promotes the progression of gastric cancer through the NF-κB pathway regulated by the MAPK and PI3K.
Liu J; Liu Q; Wan Y; Zhao Z; Yu H; Luo H; Tang Z
Int J Oncol; 2014 Jul; 45(1):282-90. PubMed ID: 24756245
[TBL] [Abstract][Full Text] [Related]
19. Hypoxia-driven osteopontin contributes to breast tumor growth through modulation of HIF1α-mediated VEGF-dependent angiogenesis.
Raja R; Kale S; Thorat D; Soundararajan G; Lohite K; Mane A; Karnik S; Kundu GC
Oncogene; 2014 Apr; 33(16):2053-64. PubMed ID: 23728336
[TBL] [Abstract][Full Text] [Related]
20. Role of osteopontin in cellular signaling and metastatic phenotype.
El-Tanani MK
Front Biosci; 2008 May; 13():4276-84. PubMed ID: 18508510
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
